{"paper_id":"a49b2932-2a15-4ba7-b734-bbecfe9e8b9f","body_text":"Abstract\nEndometriosis is a chronic inflammatory disorder with a complex genetic etiology. The interleukin-17 (IL-17) family, particularly IL-17 A and IL-17 F, plays a critical role in driving pro-inflammatory responses within the peritoneal cavity. This case-control study investigated the association of IL17A rs2275913 and IL17F rs763780 polymorphisms with endometriosis risk and severity in 208 surgically confirmed patients and 205 age-matched healthy controls from an Iranian population. Genotyping was performed using PCR-RFLP. Logistic regression analysis was used to assess associations with disease risk and clinical stage (I-II vs. III-IV). The IL17A rs2275913 AA genotype (OR = 1.98, 95% CI: 1.04–3.77, p = 0.038) and A allele (OR = 1.49, 95% CI: 1.10–2.02, p = 0.009) were associated with increased endometriosis risk. For IL17F rs763780, the AG (OR = 1.68, 95% CI: 0.98–2.88, p = 0.048) and GG (OR = 3.69, 95% CI: 1.00-13.60, p = 0.044) genotypes and the G allele (OR = 1.98, 95% CI: 1.26–3.12, p = 0.003) were significant risk factors. The combined GA (IL17A) / AG (IL17F) genotype showed an almost 8-fold increased risk (OR = 7.52, 95% CI: 2.16–26.19, p = 0.001). Both variant genotypes were significantly more frequent in moderate/severe (stage III-IV) than in minimal/mild disease (stage I-II) (p < 0.01). After Bonferroni correction (p < 0.025), the IL17A A allele, IL17F dominant model, IL17F G allele, the combined GA/AG genotype, and both severity associations remained significant. Our findings indicate that IL17A rs2275913 and IL17F rs763780 polymorphisms independently influence endometriosis susceptibility and may contribute to disease progression, serving as potential genetic biomarkers.\nData Availability\nNo datasets were generated or analysed during the current study.\nReferences\nSmolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554.\nZondervan KT, Becker CM, Missmer SA, Endometriosis. N Engl J Med. 2020;382(13):1244–56.\nFacchin F, Buggio L, Roncella E, et al. Quality of life in women with endometriosis: a narrative review. Minerva Ginecol. 2020;72(5):336–44.\nChapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666–82.\nVallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(5):564–91.\nSymons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–62.\nMăluțan AM, Drugan T, Ciortea R, et al. The role of pro-inflammatory cytokines in the pathogenesis of endometriosis. Gynecol Endocrinol. 2015;31(10):773–7.\nZhang X, Xu H, Wang J, et al. The role of Th17 cells in the pathogenesis of endometriosis. J Reprod Immunol. 2020;140:103136.\nGu C, Wu L, Li X. IL-17 family: cytokines in the pathogenesis of endometriosis. Front Immunol. 2021;12:669498.\nDelbandi AA, Mahmoudi M, Shervin B, et al. Increased circulating T helper 17 (TH17) cells and endometrial tissue IL-17-producing cells in patients with endometriosis compared with non-endometriotic subjects. Reprod Biol. 2024;25(2):101019.\nGogacz M, Winkler I, Bojarska-Junak A, et al. Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis. J Reprod Immunol. 2016;117:39–44.\nZhang X, Liu Y, Wang J, et al. Transcriptomic profiling of Th17 cells in endometriosis peritoneal fluid. Front Immunol. 2022;13:897654.\nEspinoza JL, Takami A, Nakata K, et al. A genetic variant in the IL17A promoter is associated with the development of acute GVHD after bone marrow transplantation. Bone Marrow Transpl. 2011;46(10):1364–9.\nKawaguchi M, Takahashi D, Hizawa N, et al. IL17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes the biological activity of IL-17F. J Allergy Clin Immunol. 2006;117(4):795–801.\nEdalatian Kharrazi A, Forghani F, Jahantigh D, Ghazaey Zidanloo S, Rezaei M, Taheri M. Positive correlation between Bax and Bcl-2 gene polymorphisms with the risk of endometriosis: A case-control study. Int J Reprod Biomed. 2024;22(6):451–62.\nGhaemian Moghadam R, Forghani F, Jahantigh D, Ghazey Zidanloo S, Rezaei M, Taheri M. Association of genetic variations in the PIK3-AKT-mTOR pathway with endometriosis susceptibility: a preliminary case control study. Int J Fertil Steril. 2025;19(2):164–71.\nNorouzi MA, Jahantigh D, Forghani F, Rezaei M, Ghazaey Zidanloo S. Interleukin 17 RA and RC gene polymorphisms and increased preeclampsia risk: Single and combined genetic analysis. Hum Immunol. 2025;86(2):111250.\nWang L, Jiang Y, Zhang Y, et al. Association between IL17A and IL17F gene polymorphisms and the risk of breast cancer: a meta-analysis. Oncotarget. 2017;8(46):81015–24.\nBöttcher E, Tóth B, Papp G, et al. Association of IL17A and IL17F gene polymorphisms with rheumatoid arthritis in a Hungarian cohort. Immunol Lett. 2021;235:1–7.\nZhang Y, Liu J, Liu M, et al. IL17A and IL17F gene polymorphisms and hepatitis B virus infection: a meta-analysis. J Med Virol. 2020;92(10):2230–8.\nRevised American Society for Reproductive Medicine classification of endometriosis. 1996. Fertil Steril. 1997;67(5):817–821.\nBafrani HH, Ahmadi M, Jahantigh D, Karimian M. Association analysis of the common varieties of IL17A and IL17F genes with the risk of knee osteoarthritis. J Cell Biochem. 2019;120(10):18020–30.\nKang YJ, Jeung IC, Park A, et al. IL-17A and Th17 cells contribute to endometrial cell survival by inhibiting apoptosis and NK cell mediated cytotoxicity of endometrial cells via ERK1/2 pathway. Immune Netw. 2023;23(3):e25.\nMiller JE, Ahn SH, Marks RM, et al. IL-17A modulates peritoneal macrophage function and promotes the establishment of endometriosis. FASEB J. 2020;34(8):10722–38.\nMurakami M, Ohtsuki S, Hirano T. The transcription factor NF-κB in the pathogenesis of endometriosis. Reprod Sci. 2021;28(5):1355–66.\nYu H, Wang Y, Zhang C, et al. Association between IL17A rs2275913 polymorphism and endometriosis risk: a meta-analysis. J Obstet Gynaecol Res. 2021;47(8):2675–83.\nChang SH, Dong C. A novel heterodimeric cytokine consisting of IL-17A and IL-17F regulates inflammatory responses. Cell Res. 2007;17(5):435–40.\nSeiderer J, Elben I, Diegelmann J, et al. The role of the IL17F His161Arg polymorphism in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(5):612–9.\nParadowska-Gorycka A, Pawlik A, Romanowska-Próchnicka K, et al. IL17F gene polymorphism (rs763780) is associated with susceptibility to rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(5):689–94.\nArisawa T, Tahara T, Shibata T, et al. The influence of IL17F gene polymorphisms on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9.\nShi J, Zhang Y, Zhang F, et al. The combined effect of IL17A and IL17F gene polymorphisms on the risk of gastric cancer. Cancer Biomark. 2019;24(2):229–36.\nRahmioglu N, Nyholt DR, Montgomery GW, Zondervan KT. Genetic variants underlying endometriosis: insights from genome-wide association studies. Hum Reprod Update. 2019;25(5):587–609.\nRyu S, Lee JH, Park MS, et al. IL-17A promotes angiogenesis by inducing VEGF expression in human endothelial cells. J Immunol. 2019;202(1 Supplement):12615.\nLaschke MW, Menger MD. Basic mechanisms of vascularization in endometriosis and their clinical implications. Hum Reprod Update. 2018;24(2):207–24.\nXiong Y, Liu Y, Xiong W, et al. IL-17A promotes the epithelial-mesenchymal transition of endometrial epithelial cells in endometriosis. Mol Med Rep. 2020;22(3):2315–22.\nKang YJ, Cho HJ, Lee Y, Park A, Kim MJ, Jeung IC, Jung YW, Jung H, Choi I, Lee HG, Yoon SR. IL-17A and Th17 Cells Contribute to Endometrial Cell Survival by Inhibiting Apoptosis and NK Cell Mediated Cytotoxicity of Endometrial Cells via ERK1/2 Pathway. Immune Netw. 2023;23(2):e14. https://doi.org/10.4110/in.2023.23.e14 PMID: 37179747; PMCID: PMC10166657.\nAfzali Kiani F, Forghani F, Jahantigh D, Rezaei M, Ghazaey Zidanloo S, Taheri M. Leptin G2548A and leptin receptor Q223R gene polymorphisms are associated with an increased risk of endometriosis. Bratisl Med J. 2024;126(5):312–9.\nAcknowledgements\nThe authors would like to thank the study participants for their cooperation and the clinical staff at the gynecology and infertility clinics of Zahedan University of Medical Sciences for their assistance with patient recruitment.\nFunding\nThis work was supported by a grant (Grant No. 10898) from Zahedan University of Medical Sciences, Zahedan, Iran.\nAuthor information\nAuthors and Affiliations\nContributions\nD.J. and M.T. conceived and designed the experiments. D.J., F.F. and M.R. analyzed the data. D.J. and M.R. performed the genotyping. D.J. and M.T. wrote the first draft of the manuscript. F.F. and M.R. contributed to the writing of the manuscript. All authors reviewed and approved the final manuscript.\nCorresponding authors\nEthics declarations\nCompeting Interests\nThe authors declare no competing interests.\nEthical Approval\nEthical approval was obtained from the Ethics Committee of Zahedan University of Medical Sciences (Ethical code: IR.ZAUMS.REC.1402.438), in accordance with the Declaration of Helsinki.\nConsent to Publish\nNot applicable.\nConsent to Participate\nNot applicable.\nClinical Trial Number\nNot applicable.\nAdditional information\nPublisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.\nAbout this article\nCite this article\nJahantigh, D., Taheri, M., Forghani, F. et al. Synergistic Effects of IL17A rs2275913 and IL17F rs763780 on Endometriosis Risk and Severity. Bratisl. Med. J. (2026). https://doi.org/10.1007/s44411-026-00791-z\nReceived:\nRevised:\nAccepted:\nPublished:\nVersion of record:\nDOI: https://doi.org/10.1007/s44411-026-00791-z","source_license":"CC0","license_restricted":false}